Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRTM2 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | ETF1 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | ZNF836 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | GMFG | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-06 |
mRNA | SLC50A1 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
mRNA | DOK6 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | SMIM24 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | ZNF808 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | ZADH2 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | CHRM4 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |